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Abstract
Inadequate reporting is problematic for several reasons. If authors do not provide sufficient details
concerning the conduct of their study, readers are left with an incomplete picture of what was
done. As such, they are not able to judge the merits of the results and interpret them. The
EQUATOR Network is a new initiative aimed at improving the clarity and transparency of
reporting health research.
The reporting of medical research is not clear 
and transparent: an unacceptable scandal
Mental health continues to be a major health concern in
many parts of the world. It is estimated that 5% to 10% of
people are affected by depression [1]. In 2006 the United
States National Institutes of Health spent US$335 million
on research into depression. Yet reports of randomized tri-
als evaluating interventions to optimally manage individ-
uals with depression are disturbingly inadequate, likely
making their results of limited use to healthcare profes-
sionals, other decision makers and patients. Hotopf and
colleagues [2] examined reports of 122 randomized con-
trolled trials (RCTs) evaluating medical interventions for
managing individuals with depression and found that
only one provided any details about the randomization
process used. Empirical evidence shows that inadequate
reporting of randomization, a core feature of any rand-
omized trial, is associated with biased estimates of the
treatment effect of the order of 20% [3]. Such problems
are not unique to reports from depression trials. Inade-
quate reporting is pervasive to almost every area of health
research [4-6]. Without complete, clear and transparent
reports, readers cannot judge the reliability and usefulness
of health research.
In the late 1970s the International Committee of Medical
Journal Editors (ICMJE) published reporting guides for
authors. These were limited only to formatting issues [7]
although later the ICJME developed the 'Uniform
Requirements for Manuscripts Submitted to Biomedical
Journals' with a much broader scope [8]. Other efforts
have also been made [9,10] although few focused on
reporting the design, conduct and analysis of health
research. In the mid-1990s the CONSORT Statement, a
22-item checklist and flow diagram, provided what might
be considered the first reporting guideline focusing on
what should be included in scientific reports of RCTs [11].
Evidence shows that use of CONSORT improves the qual-
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ity of reporting of RCTs [12]. Journals increasingly find
the CONSORT reporting guideline useful; more than 300
of them now directly endorse the CONSORT Statement
[13].
The last decade has witnessed considerable activity in
developing reporting guidelines: more than 80 of them
now exist. They cover a broad spectrum; examples include
recommendations for specific study designs (for example,
diagnostic accuracy studies [14]), types of data (for exam-
ple, harms assessed in randomized trials [15]) and sharing
of data for microarray experiments (see, for example,
[16]). Although a core set of steps are required to opti-
mally develop any reporting guideline, a recent survey of
30 developers of reporting guidelines suggests that most
guidelines are created idiosyncratically [17]. Contributing
factors include lack of a central repository of available
guidelines and a paucity of literature to inform developers
of how to develop a reporting guideline [18].
To help improve the quality of reporting health research,
we established the EQUATOR (Enhancing the QUAlity
and Transparency Of health Research) Network [19] with
initial funding from the UK NHS National Knowledge
Service and National Institute for Health Research. This
new initiative seeks to improve the quality of scientific
publications by promoting transparent and accurate
reporting. The network is developing resources and train-
ing related to the reporting of health research and will
assist in the development, dissemination and implemen-
tation of robust reporting guidelines. A free newsletter is
available electronically from the Network's website [19].
The Network has five major goals. First, for which there
has already been some development, is to build a compre-
hensive web-based resource centre to develop and main-
tain up-to-date information, tools and other materials
related to reporting health research. One of our first prior-
ities is to develop online resources for editors and peer
reviewers, including available literature, related to teach-
ing scientific writing and reporting.
Second, is to set up a network of reporting guideline
developers and to initiate and maintain mutual collabora-
tion. Developing reporting guidelines is a new research
activity and we are keen to act as a 'bridge' to bring
together network members and provide them with scien-
tific support for their guideline development. We are also
working to fill the gap in the literature on how to opti-
mally develop reporting guidelines.
Third, is to actively promote reporting guidelines and
their use by developing online training courses for editors,
peer reviews and researchers, and other activities raising
awareness of the importance of reporting guidelines.
Given the large number and broad scope of reporting
guidelines it is possible that funders of health research
will see them as an increasingly helpful resource to ensure
that researchers they fund use appropriate guidelines to
report their research. While this is at the end of the knowl-
edge generation cycle, funders might also see the report-
ing guides as an important resource for helping to
improve the quality of health research design and con-
duct.
Fourth, is to conduct a regular assessment of how journals
implement reporting guidelines. If reporting guidelines
are to achieve their intended goal it is important that they
are endorsed appropriately in journals. Recent data indi-
cate substantial room for improvement in this area [20].
Last, is to conduct an annual audit of reporting quality
across the health literature. Most journals do not have an
objective mechanism for gauging the quality of their pub-
lished health research. We are proposing to complete an
annual audit of the indexed literature and provide this
feedback to the journals included on our sample. Contin-
ual annual monitoring of the literature will provide
unique data on the influence reporting guidelines have on
published literature and enable the EQUATOR Network
to indirectly monitor its own progress.
The EQUATOR Network will hold its official launch meet-
ing on 26 June 2008 in London, UK. The meeting will
focus on a better understanding of the problems associ-
ated with health research reporting, the use of reporting
guidelines and on finding potential solutions that could
lead to an improvement of the health research literature.
This is an open meeting that will be preceded by a half-day
workshop for editors (see [19]).
In working to achieve these goals the EQUATOR Network
will help ensure that the clarity and transparency of
healthcare research is optimal for decisions made by
healthcare professionals, funders, editors, peer reviewers,
and readers.
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